Shigeru Imoto

9PUBLICATIONS
61CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Aboriginal and Torres Strait Islander technical, further, continuing and community educationPredictive and prognostic markersWomen's studies (incl. girls' studies)English language
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|May 04, 2026
First- Versus Second- or Subsequent-Line Use of Cyclin-Dependent Kinase 4/6 Inhibitors for Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Metastatic or Recurrent Breast Cancer: A Multicenter, Retrospective Cohort Study.

|Mar 19, 2026
Long-term outcomes of eribulin‑based neoadjuvant chemotherapy for triple‑negative breast cancer patients stratified by homologous recombination deficiency status: results of the randomized JBCRG-22 study.

Norikazu Masuda, Hiroyuki Yasojima, Hiroko Bando

|May 29, 2025
What Changes are Mandatory in Breast Surgery Training? An International Survey and Recommendations of the French Academy of Surgery and the Senologic International Society.

Tolga Ozmen, Caroline Bouche, Megane Buttignol

|May 25, 2025
Axillary surgery in patients with breast cancer with one to three positive micro- or macrometastases in the sentinel lymph nodes: an observational study.

Shigeru Imoto, Hiroyuki Yasojima, Takeshi Nagashima

|Jul 07, 2023
Current Challenges and Perspectives in Breast Cancer in Elderly Women: The Senologic International Society (SIS) Survey.

Louise Scheer, Massimo Lodi, Tolga Özmen

|Jan 23, 2023
Survival advantage of locoregional and systemic therapy in oligometastatic breast cancer: an international retrospective cohort study (OLIGO-BC1).

Shigeru Imoto, Kun Wang, Xi-Wen Bi

Pageof 2

Frequent Collaborators

4 joint publications

Carole Mathelin

4 joint publications

Schlomo Schneebaum

4 joint publications

Tadeusz Pieńkowski

4 joint publications

Vahit Özmen